The Total Brain Ltd (ASX: TTB) share price is rebounding after hitting an all-time low of 9.4 cents on Friday. This comes after the digital mental health software-as-a-service (SaaS) company announced a data licensing agreement that has excited investors.
At the time of writing, Total Brain shares are surging a whopping 57.89% to 15 cents apiece.
Total Brain secures data licensing agreement
In a statement to the ASX, Total Brain advised it has entered into a perpetual, non-exclusive licence with Janssen Research & Development, LLC.
Founded in 2001, Janssen supports the pharmaceutical business of global healthcare behemoth, Johnson & Johnson.
Janssen specialises in researching, developing, and producing medicines for a range of diseases. This relates to areas such as cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuroscience, oncology, and pulmonary hypertension.
Under the agreement, Janssen will have access to Total Brain’s iSPOT-D (International Study to Predict Optimized Treatment for Depression) research data. The licensing deal is effective immediately.
As such, Total Brain will receive a one-off licence fee of US$2.2 million within the next 90 days.
This will indeed boost the company’s cash runway significantly for research activities beyond the June 2022 quarter. Previously, Total Brain had $2.6 million at the end of September 2021.
More on Total Brain
Based in San Francisco and Sydney, Total Brain has developed the world’s first mental health self-monitoring and self-care platform.
Its SaaS platform has helped more than 1 million users scientifically measure and optimise their brain capacities while managing the risk of common mental conditions.
These benefits for employers, large organisations, and insurers have translated to productivity improvements and healthcare cost reduction.
Total Brain share price snapshot
Over the past 12 months, the Total Brain share price has lost around 52%. It is also down roughly 53% this year to date. It is a stark contrast from when the company’s shares reached a 52-week high of 50.5 cents in January 2021.
On valuation grounds, Total Brain presides a market capitalisation of about $17.34 million, with 133.39 million shares outstanding.
The post Here’s why the Total Brain (ASX:TTB) share price is rocketing 58% today appeared first on The Motley Fool Australia.
Should you invest $1,000 in Total Brain right now?
Before you consider Total Brain, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Total Brain wasn’t one of them.
The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of August 16th 2021
- Will the CBA (ASX:CBA) share price smash its record high in 2022?
- Meme coin selling: Why Shiba Inu, Dogecoin, and The Sandbox are down
- Could the Aurizon (ASX:AZJ) share price be in for more pain in 2022?
- Woolworths (ASX:WOW) share price rises as boss courts API pharmacists
- Magellan (ASX:MFG) shares just lost $1.8b of market cap. What now?
from The Motley Fool Australia https://ift.tt/3J6VvON